Katerina Akassoglou Selected Research

Katerina Akassoglou Research Topics

Disease

15	Multiple Sclerosis 01/2023 - 04/2004
14	Neuroinflammatory Diseases 04/2024 - 04/2004
12	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 06/2004
11	Inflammation (Inflammations) 04/2024 - 04/2004
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2023 - 03/2007
6	Demyelinating Diseases (Demyelinating Disease) 11/2023 - 04/2004
6	Cognitive Dysfunction 01/2022 - 12/2011
6	Infections 11/2021 - 06/2008
5	Stroke (Strokes) 01/2015 - 06/2004
3	Gliosis 11/2023 - 04/2010
3	Thrombosis (Thrombus) 10/2021 - 01/2012
3	Cicatrix (Scar) 01/2020 - 04/2010
3	Paralysis (Palsy) 01/2017 - 03/2007
3	Hypoxia (Hypoxemia) 03/2012 - 06/2008
3	Rupture 04/2010 - 06/2004
2	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2024 - 01/2012
2	Wounds and Injuries (Trauma) 01/2023 - 01/2018
2	Neoplasms (Cancer) 01/2021 - 01/2012
2	Brain Injuries (Brain Injury) 01/2020 - 12/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018 - 06/2004
2	Autoimmune Diseases (Autoimmune Disease) 10/2017 - 03/2007
2	Insulin Resistance 01/2016 - 04/2012
2	Fibrosis (Cirrhosis) 01/2012 - 06/2007
2	Bacterial Infections (Bacterial Infection) 01/2012 - 06/2008
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 11/2023
1	Systemic Scleroderma (Systemic Sclerosis) 01/2023
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2023
1	COVID-19 10/2021
1	Thromboinflammation 10/2021
1	Tauopathies 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Amyloid Plaque 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Frontotemporal Dementia (Semantic Dementia) 01/2017
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2017
1	Weight Gain 01/2016
1	Obesity 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Hyperglycemia 01/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2016
1	Encephalomyelitis (Myeloencephalitis) 09/2015
1	Endotoxemia 03/2015
1	Sepsis (Septicemia) 08/2014

Drug/Important Bio-Agent (IBA)

21	Fibrinogen (Factor I)FDA Link 04/2024 - 03/2007
12	FibrinIBA 04/2024 - 01/2002
8	Proteins (Proteins, Gene)FDA Link 10/2021 - 06/2004
7	Blood Proteins (Serum Proteins)IBA 04/2024 - 04/2004
5	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2016 - 06/2007
3	EpitopesIBA 10/2021 - 03/2007
3	Blood Coagulation Factors (Coagulation Factor)IBA 10/2021 - 01/2021
3	PlasminogenIBA 01/2017 - 06/2007
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
2	Thrombin FDA Link 11/2021 - 02/2014
2	Monoclonal AntibodiesIBA 10/2021 - 11/2018
2	Therapeutic UsesIBA 01/2021 - 01/2020
2	Fibrinolysin FDA Link 01/2017 - 01/2015
2	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 01/2016 - 03/2012
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2015 - 12/2011
2	LipopolysaccharidesIBA 03/2015 - 08/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013 - 11/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2004 - 01/2003
1	Interleukin-18 (Interleukin 18)IBA 11/2023
1	InflammasomesIBA 11/2023
1	CuprizoneIBA 11/2023
1	Clodronic Acid (Clodronate)IBA 11/2021
1	AnticoagulantsIBA 11/2021
1	SARS-CoV-2 spike proteinIBA 10/2021
1	AutoantibodiesIBA 10/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	LDL Receptors (LDL Receptor)IBA 01/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	acivicin (AT 125)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2018
1	GadoliniumIBA 01/2018
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2017
1	Glutamic Acid (Glutamate)FDA Link 10/2017
1	EnzymesIBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Tranexamic Acid (AMCA)FDA Link 01/2017
1	ProgranulinsIBA 01/2017
1	estropipate (Ogen)FDA LinkGeneric 01/2016
1	EndotoxinsIBA 01/2016
1	Chemokine CX3CL1IBA 01/2016
1	ChemokinesIBA 09/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2015
1	Sirtuin 1IBA 05/2015
1	Cholinergic Agents (Cholinergics)IBA 03/2015
1	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 08/2014
1	Peptide Hydrolases (Proteases)FDA Link 02/2014

Therapy/Procedure

2	Immunotherapy 10/2021 - 11/2018
2	Transplantation 11/2017 - 01/2016
2	Lasers (Laser) 08/2014 - 12/2012
1	Therapeutics 11/2023
1	Orthopedic Procedures 03/2015
1	Laser Therapy (Surgery, Laser) 08/2014